Cost of surviving sepsis: a novel model of recovery from sepsis in Drosophila melanogaster.

Ata Murat Kaynar, Veli Bakalov, Silvia Martinez Laverde, Am��lie I F Cambriel, Byoung-Hoon Lee, Atif Towheed, Alyssa D Gregory, Steven A R Webb, Michael J Palladino, Fernando A Bozza, Steven D Shapiro, Derek C Angus
Author Information
  1. Ata Murat Kaynar: Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, 612 Scaife Hall, 3550 Terrace Street, Pittsburgh, 15261, PA, USA. kaynarm@upmc.edu.
  2. Veli Bakalov: Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, 612 Scaife Hall, 3550 Terrace Street, Pittsburgh, 15261, PA, USA.
  3. Silvia Martinez Laverde: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA.
  4. Am��lie I F Cambriel: Universit�� Paris Descartes, 75270, Paris, Cedex 06, France.
  5. Byoung-Hoon Lee: Department of Pulmonology and Allergy, Eulji University, Seoul, 139-711, Korea.
  6. Atif Towheed: Department of Pharmacology and Chemical Biology, Pittsburgh, PA, 15260, USA.
  7. Alyssa D Gregory: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA.
  8. Steven A R Webb: School of Population Health, University of Western Australia, Crawly, Perth, WA, 6009, Australia.
  9. Michael J Palladino: Department of Pharmacology and Chemical Biology, Pittsburgh, PA, 15260, USA.
  10. Fernando A Bozza: Instituto de Pesquisa Cl��nica Evandro Chagas, Funda����o Oswaldo Cruz, Rio de Janeiro, 21040-360, Brazil.
  11. Steven D Shapiro: Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USA.
  12. Derek C Angus: Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Laboratory, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, 612 Scaife Hall, 3550 Terrace Street, Pittsburgh, 15261, PA, USA.

Abstract

BACKGROUND: Multiple organ failure, wasting, increased morbidity, and mortality following acute illness complicates the health span of patients surviving sepsis. Persistent inflammation has been implicated, and it is proposed that insulin signaling contributes to persistent inflammatory signaling during the recovery phase after sepsis. However, mechanisms are unknown and suitable pre-clinical models are lacking. We therefore developed a novel Drosophila melanogaster model of sepsis to recapitulate the clinical course of sepsis, explored inflammation over time, and its relation to impaired mobility, metabolic disturbance, and changes in lifespan.
METHODS: We used wild-type (WT), Drosomycin-green fluorescent protein (GFP), and NF-��B-luc reporter male Drosophila melanogaster 4-5 days of age (unmanipulated). We infected Drosophila with Staphylococcus aureus (infected without treatment) or pricked with aseptic needles (sham). Subsets of insects were treated with oral linezolid after the infection (infected with antibiotics). We assessed rapid iterative negative geotaxis (RING) in all the groups as a surrogate for neuromuscular functional outcome up to 96 h following infection. We harvested the flies over the 7-day course to evaluate bacterial burden, inflammatory and metabolic pathway gene expression patterns, NF-��B translation, and metabolic reserve. We also followed the lifespan of the flies.
RESULTS: Our results showed that when treated with antibiotics, flies had improved survival compared to infected without treatment flies in the early phase of sepsis up to 1 week (81 %, p���=���0.001). However, the lifespan of infected with antibiotics flies was significantly shorter than that of sham controls (p���=���0.001). Among infected with antibiotic sepsis survivors, we observed persistent elevation of NF-��B in the absence of any obvious infection as shown by culturing flies surviving sepsis. In the same group, geotaxis had an early (18 h) and sustained decline compared to its baseline. Geotaxis in infected with antibiotics sepsis survivors was significantly lower than that in sham and age-matched unmanipulated flies at 18 and 48 h. Expression of antimicrobial peptides (AMP) remained significantly elevated over the course of 7 days after sepsis, especially drosomycin (5.7-fold, p���=���0.0145) on day 7 compared to that of sham flies. Infected with antibiotics flies had a trend towards decreased Akt activation, yet their glucose stores were significantly lower than those of sham flies (p���=���0.001). Sepsis survivors had increased lactate levels and LDH activity by 1 week, whereas ATP and pyruvate content was similar to that of the sham group.
CONCLUSIONS: In summary, our model mimics human survivors of sepsis with persistent inflammation, impaired motility, dysregulated glucose metabolism, and shortened lifespan.

Keywords

References

  1. Crit Care. 2014 Sep 03;18(5):469 [PMID: 25182529]
  2. PLoS One. 2011;6(8):e22847 [PMID: 21853050]
  3. Antimicrob Agents Chemother. 2007 Mar;51(3):962-7 [PMID: 17194826]
  4. J Trauma Acute Care Surg. 2012 Jun;72(6):1491-501 [PMID: 22695412]
  5. Gene. 2006 Sep 1;379:26-32 [PMID: 16824706]
  6. J Trauma Acute Care Surg. 2014 Jan;76(1):21-9; discussion 29-30 [PMID: 24368353]
  7. J Vis Exp. 2012 Dec 04;(70):e4355 [PMID: 23242373]
  8. JAMA. 1997 Apr 2;277(13):1058-63 [PMID: 9091694]
  9. J Biol Chem. 2012 Jul 27;287(31):25758-69 [PMID: 22700961]
  10. Proc Biol Sci. 2002 Apr 22;269(1493):817-21 [PMID: 11958713]
  11. PLoS Pathog. 2007 Mar;3(3):e26 [PMID: 17352533]
  12. JAMA. 2010 Oct 27;304(16):1787-94 [PMID: 20978258]
  13. J Immunol. 2011 Jan 1;186(1):195-202 [PMID: 21106855]
  14. Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20853-8 [PMID: 19861550]
  15. J Biol Chem. 2006 Apr 14;281(15):10105-17 [PMID: 16492665]
  16. Cell Metab. 2015 Jan 6;21(1):65-80 [PMID: 25565206]
  17. Genetics. 2013 May;194(1):133-42 [PMID: 23502677]
  18. Am J Physiol. 1997 Nov;273(5 Pt 2):R1631-7 [PMID: 9374803]
  19. Science. 2014 Sep 26;345(6204):1250684 [PMID: 25258083]
  20. J Clin Invest. 2013 Sep;123(9):3685-92 [PMID: 23999443]
  21. J Immunol. 2010 Feb 1;184(3):1200-9 [PMID: 20026743]
  22. Aging Cell. 2011 Oct;10(5):735-48 [PMID: 21443682]
  23. Exp Gerontol. 2005 May;40(5):386-95 [PMID: 15919590]
  24. Curr Biol. 2006 Nov 21;16(22):R964-5 [PMID: 17113379]
  25. Crit Care Med. 2001 Jul;29(7):1303-10 [PMID: 11445675]
  26. J Biol Chem. 2014 Sep 5;289(36):25227-40 [PMID: 24990947]
  27. Curr Infect Dis Rep. 2007 Sep;9(5):382-6 [PMID: 17880848]
  28. Mol Immunol. 2008 Feb;45(3):810-7 [PMID: 17681604]
  29. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14614-9 [PMID: 9405661]
  30. Arch Intern Med. 2007 Aug 13-27;167(15):1655-63 [PMID: 17698689]
  31. Proc Biol Sci. 2004 May 7;271(1542):925-30 [PMID: 15255047]
  32. Science. 2009 May 22;324(5930):1029-33 [PMID: 19460998]
  33. PLoS Biol. 2009 Jul;7(7):e1000150 [PMID: 19597539]
  34. J Clin Endocrinol Metab. 2014 May;99(5):1569-82 [PMID: 24517153]
  35. Nature. 2004 Jun 3;429(6991):562-6 [PMID: 15175753]
  36. JAMA. 2014 Apr 2;311(13):1308-16 [PMID: 24638143]
  37. Infect Immun. 2005 May;73(5):2751-7 [PMID: 15845478]
  38. Nat Protoc. 2009;4(9):1285-94 [PMID: 19680242]
  39. PLoS One. 2012;7(12):e50679 [PMID: 23272066]

Grants

  1. K08 HL086671/NHLBI NIH HHS
  2. R01 HL126711/NHLBI NIH HHS

Word Cloud

Created with Highcharts 10.0.0sepsisfliesinfectedshamDrosophilaantibioticslifespanp���=���0significantlysurvivorssurvivinginflammationpersistentmelanogastermodelcoursemetabolicinfectioncompared001increasedfollowingsignalinginflammatoryrecoveryphaseHowevernovelimpairedunmanipulatedwithouttreatmenttreatedgeotaxisNF-��Bearly1 weekgrouplowerAktglucoseSepsisBACKGROUND:MultipleorganfailurewastingmorbiditymortalityacuteillnesscomplicateshealthspanpatientsPersistentimplicatedproposedinsulincontributesmechanismsunknownsuitablepre-clinicalmodelslackingthereforedevelopedrecapitulateclinicalexploredtimerelationmobilitydisturbancechangesMETHODS:usedwild-typeWTDrosomycin-greenfluorescentproteinGFPNF-��B-lucreportermale4-5 daysageStaphylococcusaureusprickedasepticneedlesSubsetsinsectsorallinezolidassessedrapiditerativenegativeRINGgroupssurrogateneuromuscularfunctionaloutcome96 hharvested7-dayevaluatebacterialburdenpathwaygeneexpressionpatternstranslationreservealsofollowedRESULTS:resultsshowedimprovedsurvival81 %shortercontrolsAmongantibioticobservedelevationabsenceobviousshownculturing18 hsustaineddeclinebaselineGeotaxisage-matched1848 hExpressionantimicrobialpeptidesAMPremainedelevated7 daysespeciallydrosomycin57-fold0145day7InfectedtrendtowardsdecreasedactivationyetstoreslactatelevelsLDHactivitywhereasATPpyruvatecontentsimilarCONCLUSIONS:summarymimicshumanmotilitydysregulatedmetabolismshortenedCostsepsis:DrosomycinInsulinRecovery

Similar Articles

Cited By